Piper Therapeutics Inc. logo

Piper Therapeutics Inc.

Piper Therapeutics Inc. is a pre-clinical drug discovery company developing therapies that affect inflammatory signaling and immune system response, with applications to immuno-oncology, sepsis and automimmune disorders.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.pipertx.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
One Broadway, 14th Floor, MA, 02142
Cambridge
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/piper-therapeutics-inc” connections=”true” suffix=””]

Piper Therapeutics is developing molecules to influence the tumor microenvironment to prevent tumor transformation of inflammatory and immune cells into pro-cancer support cells.

In Sep 2015, Piper Therapeutics raised about $1.50 Mn in debt financing.